Med. praxi. 2017;14(1):11-14 | DOI: 10.36290/med.2017.003

Patient motivation for lifelong use of antihypertensive medication

doc. MUDr. Ondřej Ludka, Ph.D.
Interní kardiologická klinika FN Brno, Lékařská fakulta MU, Brno, Mezinárodní centrum klinického výzkumu, FN u sv. Anny v Brně

Compliance to the treatment with medical drugs consists of persistence with drugs use in the time and adherence with every day

use. Compliance to lifelong treatment of arterial hypertension is a major problem of our time. The article provides information

about the compliance of patients with hypertension and options for improvement. Are presented the advantages of combination

therapy of hypertension, but also a potential risk of drug interactions in patients with polypharmacy.

Keywords: compliance with therapy, arterial hypertension, combined therapy

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ludka O. Patient motivation for lifelong use of antihypertensive medication. Med. praxi. 2017;14(1):11-14. doi: 10.36290/med.2017.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. The Komparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360. Go to original source... Go to PubMed...
    2. Cífková R, Bruthans J, Adámková V, a kol. Prevalence základních kardiovaskulárních rizikových faktorů v české populaci letech 2006-2009. Studie Czech post-MONICA. Cor Vasa 2011; 53: 220-229. Go to original source...
    3. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Br Med J 2008; 336: 1114-1117. Go to original source... Go to PubMed...
    4. Kettani FZ, Dragomir A, Côté R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40(1): 213-220. Go to original source... Go to PubMed...
    5. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24: 121-127. Go to original source...
    6. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-1605. Go to original source...
    7. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906. Go to original source...
    8. Bramlage P, Böhm M, Volpe M, et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens 2010; 12: 66-77. Go to original source...
    9. Coleman CI, Roberts MS, Sobieraj DM, et al. Effect of dosing frequency on chronic cardiovascular disease medication adherence. Current Medical Research Opinion 2012; 28: 669-680. Go to original source... Go to PubMed...
    10. Weber MA, Schiffrin EL, White WB, et al. Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension. Journal of Hypertension 2014; 32: 3-15. Go to original source...
    11. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122(3): 290-300. Go to original source... Go to PubMed...
    12. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55(2): 399-407. Go to original source...
    13. Rosolová H. Jak zlepšit dodržování léčby u pacienta v primární prevenci kardiovaskulárních nemocí? Medicína po promoci 2013; 14: 67-71.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.